These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

676 related items for PubMed ID: 26628405

  • 41. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
    Chen X, Xu Y, Liao X, Liao R, Zhang L, Niu K, Li T, Li D, Chen Z, Duan Y, Sun J.
    Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
    [Abstract] [Full Text] [Related]

  • 42. Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia.
    Dong R, Shen Z, Zheng C, Chen G, Zheng S.
    Sci Rep; 2016 Feb 16; 6():21084. PubMed ID: 26879603
    [Abstract] [Full Text] [Related]

  • 43. Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases.
    Yan HB, Zhang Y, Cen JM, Wang X, Gan BL, Huang JC, Li JY, Song QH, Li SH, Chen G.
    Med Sci Monit; 2018 Jul 12; 24():4807-4822. PubMed ID: 29997385
    [Abstract] [Full Text] [Related]

  • 44. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
    Li Z, Peng Z, Gu S, Zheng J, Feng D, Qin Q, He J.
    Anticancer Res; 2017 Aug 12; 37(8):4455-4468. PubMed ID: 28739740
    [Abstract] [Full Text] [Related]

  • 45. Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma.
    Zhang Q, Luo Y, Zhang S, Huang Q, Liu G.
    Sci Rep; 2024 Feb 21; 14(1):4257. PubMed ID: 38383747
    [Abstract] [Full Text] [Related]

  • 46. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
    Yan ZY, Luo ZQ, Zhang LJ, Li J, Liu JQ.
    J Cell Physiol; 2017 Aug 21; 232(8):2178-2185. PubMed ID: 27935034
    [Abstract] [Full Text] [Related]

  • 47. HPV16+ -miRNAs in cervical cancer and the anti-tumor role played by miR-5701.
    Pulati N, Zhang Z, Gulimilamu A, Qi X, Yang J.
    J Gene Med; 2019 Nov 21; 21(11):e3126. PubMed ID: 31498525
    [Abstract] [Full Text] [Related]

  • 48. Establishing a three-miRNA signature as a prognostic model for colorectal cancer through bioinformatics analysis.
    Wang Y, Huang L, Shan N, Ma H, Lu S, Chen X, Long H.
    Aging (Albany NY); 2021 Aug 13; 13(15):19894-19907. PubMed ID: 34388112
    [Abstract] [Full Text] [Related]

  • 49. Identification of key genes and miRNAs markers of papillary thyroid cancer.
    Qiu J, Zhang W, Zang C, Liu X, Liu F, Ge R, Sun Y, Xia Q.
    Biol Res; 2018 Nov 10; 51(1):45. PubMed ID: 30414611
    [Abstract] [Full Text] [Related]

  • 50. Analysis of the Role and Regulatory Mechanism of hsa-miR-504 in Cervical Cancer Based on The Cancer Genome Atlas Database.
    Li D, Liu SH, Liu QY, Zou QQ, Lv L, Liu GL, Wu Y.
    Cancer Biother Radiopharm; 2021 Aug 10; 36(6):511-520. PubMed ID: 32589477
    [Abstract] [Full Text] [Related]

  • 51. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
    Mou T, Zhu D, Wei X, Li T, Zheng D, Pu J, Guo Z, Wu Z.
    World J Surg Oncol; 2017 Mar 16; 15(1):63. PubMed ID: 28302149
    [Abstract] [Full Text] [Related]

  • 52. [Prognosis-related miRNA bioinformatics screening of lung adenocarcinoma and its clinical significance].
    Zhang HM, Yang B, Chen HF, Chi XH, Xi YB, Chen XM, Guo B, He PF, Lu XC.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jun 08; 34(6):530-535. PubMed ID: 31032588
    [Abstract] [Full Text] [Related]

  • 53. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
    Yang G, Zhang Y, Yang J.
    Front Oncol; 2019 Jun 08; 9():1207. PubMed ID: 31799184
    [Abstract] [Full Text] [Related]

  • 54. A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data.
    Shi XH, Li X, Zhang H, He RZ, Zhao Y, Zhou M, Pan ST, Zhao CL, Feng YC, Wang M, Guo XJ, Qin RY.
    Sci Rep; 2018 May 16; 8(1):7638. PubMed ID: 29769534
    [Abstract] [Full Text] [Related]

  • 55. MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches.
    Aghaee-Bakhtiari SH, Arefian E, Naderi M, Noorbakhsh F, Nodouzi V, Asgari M, Fard-Esfahani P, Mahdian R, Soleimani M.
    Tumour Biol; 2015 Jun 16; 36(6):4203-12. PubMed ID: 25604141
    [Abstract] [Full Text] [Related]

  • 56. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
    Krishnan P, Ghosh S, Wang B, Li D, Narasimhan A, Berendt R, Graham K, Mackey JR, Kovalchuk O, Damaraju S.
    BMC Genomics; 2015 Sep 29; 16():735. PubMed ID: 26416693
    [Abstract] [Full Text] [Related]

  • 57. Potential Five-MicroRNA Signature Model for the Prediction of Prognosis in Patients with Wilms Tumor.
    Gong Y, Zou B, Chen J, Ding L, Li P, Chen J, Chen J, Zhang B, Li J.
    Med Sci Monit; 2019 Jul 22; 25():5435-5444. PubMed ID: 31328722
    [Abstract] [Full Text] [Related]

  • 58. Diagnostic and prognostic values of tissue hsa-miR-30c and hsa-miR-203 in prostate carcinoma.
    Huang Z, Zhang L, Yi X, Yu X.
    Tumour Biol; 2016 Apr 22; 37(4):4359-65. PubMed ID: 26499781
    [Abstract] [Full Text] [Related]

  • 59. Research on the typical miRNA and target genes in squamous cell carcinoma and adenocarcinoma of esophagus cancer with DNA microarray.
    Wang HB, Jiang ZB, Li M.
    Pathol Oncol Res; 2014 Apr 22; 20(2):245-52. PubMed ID: 24519530
    [Abstract] [Full Text] [Related]

  • 60. Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma.
    Zheng R, Mao W, Du Z, Zhang J, Wang M, Hu M.
    Biochem Biophys Res Commun; 2018 Dec 09; 507(1-4):377-382. PubMed ID: 30442364
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.